Computational design of insulin proteins that bind to the insulin receptor and "induce different downstream responses."
"We identified designs more potent than insulin, causing longer-lasting glucose lowering in vivo and retaining activity on disease-causing IR mutants..." in mice.
Nice paper from David Baker's group. They made insulin variants that bind to many different parts of the receptor, including partial agonists that bias downstream signaling away from MAPK. The authors solved many of the bound structures as well.